Home Ingredients inavea™ CINNAMON ACACIA
Metabolic HealthCardiovascular

inavea™ CINNAMON ACACIA

Evidence Level
Limited
2 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

inavea™ cinnamon acacia is an organic synergistic formulation developed by Nexira (France) — combining cinnamon (Cinnamomum verum / cassia) and acacia gum for metabolic health applications. Studied in an animal (in vivo) high-fat/high-sucrose dysbiosis model, where it was associated with improved glucose and insulin markers and prebiotic activity at 5 g/day; human efficacy trials of the blend itself have not yet been published, increased short-chain fatty acid (propionate and butyrate) production reported in in-vitro fermentation of its acacia component, and carbon neutral organic certification. Combines cinnamon's polyphenols (PACs) with acacia's prebiotic fiber for dual mechanism metabolic support.

Studied Dose 5 g/day.
Active Compound Cinnamon polyphenols (PACs) + acacia gum prebiotic fiber.

Benefits

Glucose and Insulin Markers (Animal Model + Cinnamon Component Data)

In an animal (in vivo) high-fat/high-sucrose dysbiosis model, inavea™ cinnamon acacia was associated with improved blood glucose and insulin markers versus controls; this has not been confirmed in human trials of the blend. Mechanism: cinnamon glucose modulation plus acacia prebiotic effects.

Supported by Trial 1

Strong Prebiotic Activity

Significant ability to modulate overall gut microbiota at 5 g/day, promoting beneficial bacteria including Parabacteroides distasonis in the animal model; that species' metabolic-health associations come from separate, largely preclinical literature, not from human trials of this blend.

Supported by Trial 1

Increased SCFA Production (acacia component, in-vitro)

Specifically increases propionate and butyrate (SCFAs with metabolic health benefits) — propionate may support gluconeogenesis modulation and satiety, and butyrate serves as colonocyte fuel; these are mechanistic roles described for SCFAs generally, not outcomes demonstrated for this blend in humans.

Supported by Trial 1

Microbiome Modulation Under Metabolic Stress

Studied specifically under dysbiosis-inducing conditions (high fat / high sucrose diet) — was studied in an animal model of such conditions. Relevant to: Western dietary patterns and general metabolic wellness. This ingredient is not intended to diagnose, treat, cure, or prevent any disease.

Supported by Trial 1

Dual Mechanism (Polyphenols + Fiber)

Combines cinnamon polyphenols (proposed insulin-mimetic and antioxidant activity) with acacia prebiotic fiber (indirect microbiome-mediated metabolic effects). Distinct mechanisms with complementary metabolic benefits.

Supported by Trial 1

Subtle Cinnamon Taste

Pleasant warming cinnamon flavor; suitable for: warm beverages, baked goods, breakfast applications, functional shots.

Supported by Trial 1, Trial 2

Mechanism of action

1

Cinnamon Polyphenol Metabolic Effects

Cinnamon contains polyphenols including proanthocyanidins (PACs), CINNAMTANNINS (B-type PACs unique to cinnamon), and other polyphenols. Mechanisms: insulin-mimetic effects (insulin receptor stimulation), enhanced glucose uptake in muscle/adipose, modulation of carbohydrate digestion enzymes.

2

Acacia Prebiotic Mechanism

Acacia gum supports beneficial bacteria, SCFA production, gut barrier — see acacia/Fibregum entries. Foundation for indirect metabolic benefits.

3

Parabacteroides distasonis Promotion

Specific bacterial species shown to support metabolic health markers (glycemia, weight); inavea™ cinnamon acacia was observed to increase this species in the animal model.

4

Propionate/Butyrate Specificity

Among SCFAs, propionate and butyrate are particularly metabolically active — increased production from this formulation supports specific metabolic health pathways.

Clinical trials

1
inavea™ cinnamon acacia Metabolic Health — Nexira In Vivo Study

In vivo study of inavea™ cinnamon acacia in high fat/high sucrose diet-induced dysbiosis model.

Animal (in vivo) model under high-fat/high-sucrose metabolic stress conditions (not human).

In this animal (in vivo) model, the blend showed prebiotic activity and gut-microbiome shifts, with improvements in glucose and insulin markers versus controls. As an animal study, it does not establish glycemic or insulin benefit in humans.

2
Cinnamon for Glycemic Control

Trial of cinnamon on glycemic markers in T2D patients.

T2D patients.

Cinnamon reduced fasting glucose and HbA1c. Reported cinnamon glycemic effects in some trials; the evidence across cinnamon trials is mixed and not settled (foundation for combination formulations).

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress with rapid introduction.
Coumarin content concern (cassia cinnamon) — Nexira specifies low coumarin content.
Allergic reactions to cinnamon rare.
Mouth/throat irritation from concentrated cinnamon possible.
Hepatotoxicity from very high cassia cinnamon intake (coumarin) — concern at very high doses; product designed for safe use.

Important Drug interactions

Diabetes medications — additive hypoglycemic effects from cinnamon; modest concern; monitor glucose.
Anticoagulants — coumarin in cassia cinnamon has theoretical anticoagulant effect; choose Ceylon cinnamon products if possible; modest concern.
Hepatotoxic medications — additive concern at very high doses (coumarin).
Pregnancy — moderate cinnamon culinary use safe; concentrated supplementation limited safety data; avoid high-dose supplementation.
Lactation — moderate use safe; high-dose supplementation limited data.

More Metabolic Health Ingredients

Metabolic Health
Psyllium Husk (Plantago ovata)
Psyllium husk is the soluble fiber derived from the seed husks of Plantago ovata — the mos…
Metabolic Health
Thiamine
Thiamine, also known as vitamin B1, is a water-soluble vitamin essential for converting ca…
Metabolic Health
Inositol (Myo-Inositol)
Inositol is a naturally occurring sugar alcohol that acts as a secondary messenger in insu…
Metabolic Health
Black Pepper Extract
Black pepper extract is derived from Piper nigrum and contains piperine — the alkaloid res…

Explore Other Ingredients

Metabolic Health
Inulin
Inulin is a soluble prebiotic fiber found naturally in chicory root, agave, and many veget…
Energy
SalidroPure™ (Pure Salidroside)
SalidroPure™ is NNB Nutrition's precision-fermented pure salidroside — the primary bioacti…
Cognitive
Ashwagandha
Ashwagandha (Withania somnifera) is an adaptogenic herb from Ayurvedic tradition, widely u…

Frequently asked questions about inavea™ CINNAMON ACACIA

What is inavea CINNAMON ACACIA?

inavea™ cinnamon acacia is an organic synergistic formulation developed by Nexira (France) — combining cinnamon (Cinnamomum verum / cassia) and acacia gum for metabolic health applications.

What is inavea CINNAMON ACACIA used for?

inavea CINNAMON ACACIA is researched primarily for Metabolic Health and Cardiovascular. In an animal (in vivo) high-fat/high-sucrose dysbiosis model, inavea™ cinnamon acacia was associated with improved blood glucose and insulin markers versus controls; this has not been confirmed in human trials of the blend.

What is the recommended dosage of inavea CINNAMON ACACIA?

The clinically studied dose is 5 g/day. Always follow the product label and check with a healthcare provider for personal advice.

Is inavea CINNAMON ACACIA safe, and does it have side effects?

For most healthy adults, inavea CINNAMON ACACIA is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. Mild GI distress with rapid introduction. It may also interact with some medications. inavea CINNAMON ACACIA is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does inavea CINNAMON ACACIA interact with any medications?

Possible interactions include: Diabetes medications — additive hypoglycemic effects from cinnamon; modest concern; monitor glucose. Anticoagulants — coumarin in cassia cinnamon has theoretical anticoagulant effect; choose Ceylon cinnamon products if possible; modest concern. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for inavea CINNAMON ACACIA?

NutraSmarts rates the evidence for inavea CINNAMON ACACIA as Limited (2 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Kutbi EH, Sohouli MH, Fatahi S, Lari A, Shidfar F, Aljhdali MM, Alhoshan FM, Elahi SS, Almusa HA, Abu-Zaid A The beneficial effects of cinnamon among patients with metabolic diseases: A systematic review and dose-response meta-analysis of randomized-controlled trials. Crit Rev Food Sci Nutr. 2022;62(22):6113-6131. doi: 10.1080/10408398.2021.1896473.PubMedUsed to support: Dose-response meta-analysis of 35 RCTs showing cinnamon supplementation ≤1.5 g/day significantly reduces fasting serum glucose (WMD −11.39 mg/dL, p<0.001) and insulin (WMD −1.27 μIU/mL, p=0.028) in metabolic disease patients. Directly supports the 'Glycemia and Insulinemia Improvement' and 'Dual Mechanism' claims for the cinnamon component. Note: evidence is on cinnamon as a component, not the inavea cinnamon-acacia blend per se.
  2. Jarrar AH, Stojanovska L, Apostolopoulos V, Feehan J, Bataineh MF, Ismail LC, Al Dhaheri AS The Effect of Gum Arabic (Acacia Senegal) on Cardiovascular Risk Factors and Gastrointestinal Symptoms in Adults at Risk of Metabolic Syndrome: A Randomized Clinical Trial. Nutrients. 2021;13(1):194. doi: 10.3390/nu13010194.PubMedUsed to support: Human RCT (n=61) showing gum arabic (acacia) improves gastrointestinal function and metabolic markers in adults at metabolic syndrome risk. Supports the 'Strong Prebiotic Activity' and 'Microbiome Modulation Under Metabolic Stress' claims for the acacia component of the blend.
  3. Alarifi S, Bell A, Walton G In vitro fermentation of gum acacia - impact on the faecal microbiota. Int J Food Sci Nutr. 2018;69(6):696-704. doi: 10.1080/09637486.2017.1404970.PubMedUsed to support: In vitro fermentation study showing gum acacia increases propionate and butyrate production alongside Bifidobacterium enrichment. Supports the 'Increased SCFA Production (Propionate and Butyrate)' claim for the acacia component of inavea cinnamon acacia.
  4. Kirkham S, Akilen R, Sharma S, Tsiami A The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes Obes Metab. 2009;11(12):1100-13. doi: 10.1111/j.1463-1326.2009.01094.x.PubMedUsed to support: Review of 8 RCTs of Cinnamomum cassia and C. verum showing antihyperglycaemic effects and reduced postprandial blood glucose (up to 18-29% in some diabetic trials). Supports the 'Glycemia and Insulinemia Improvement' and 'Dual Mechanism (Polyphenols + Fiber)' claims for the cinnamon component.